Bellinda Benhamú
Universidad Complutense de Madrid(ES)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Synthesis and Biological Evaluation, Cancer, Lipids, and Metabolism, Chemical synthesis and alkaloids
Most-Cited Works
- → Serotonin 5-HT6Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease(2014)161 cited
- → Arylpiperazine Derivatives Acting at 5-HT1A Receptors(2002)144 cited
- → Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity(2009)95 cited
- → A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines(2011)94 cited
- → A Three-Dimensional Pharmacophore Model for 5-Hydroxytryptamine6(5-HT6) Receptor Antagonists(2005)89 cited
- → Optimization of the Pharmacophore Model for 5-HT7R Antagonism. Design and Synthesis of New Naphtholactam and Naphthosultam Derivatives(2003)70 cited
- → New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity(2012)65 cited
- → Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 2. Three-Dimensional Quantitative Structure−Activity Relationships of Hydantoin−Phenylpiperazine Derivatives with Affinity for 5-HT1A and α1 Receptors. A Comparison of CoMFA Models(1997)64 cited
- → Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 1. 2-[[4-(o-Methoxyphenyl)piperazin-1-yl]methyl]-1,3- dioxoperhydroimidazo[1,5-a]pyridine: A Selective 5-HT1A Receptor Agonist(1996)63 cited
- → Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells(2014)62 cited